1-7 of 7
Alexey Aleshin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA As a Biomarker for Molecular Residual Disease Assessment in Patients with Diffuse Large B-Cell Lymphoma

Mayur Narkhede, Sarah Tomassetti, Madiha Iqbal, Katie LaBarbera, Hayley Widden, Ryan Benrud, Richa Rathore, Ekaterina Kalashnikova, Allyson Koyen Malashevich, Minetta Liu, Alexey Aleshin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11884–11886.
https://doi.org/10.1182/blood-2022-169656
Published: 2022
Journal Articles

MDS and MDS/MPN Genomic Subgroups Demonstrate Differential E x Vivo Drug Sensitivity

Michael A Spinner, Steven A Schaffert, Henning Stehr, Marianne T Santaguida, Ryosuke Kita, Alexey Aleshin, James L Zehnder, Peter L. Greenberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2021-152103
Published: 2021
Journal Articles

Correlating Clinical and Genomic Features with E x Vivo Drug Sensitivity in Patients with Myelodysplastic Syndromes and Related Myeloid Neoplasms

Michael A Spinner, MD, Steven A Schaffert, PhD, Alexey Aleshin, MD MBA, Marianne T Santaguida, PhD, Hiroomi Tada, MDPhD, Peter L. Greenberg
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140095
Published: 2020
Journal Articles

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Michael A Spinner, Alexey Aleshin, MD MBA, Marianne A Santaguida, PhD, Steven A Schaffert, PhD, Taher Abbasi, MS, MBA, Jeffrey N Sanders, A Scott Patterson, MA, Diane Heiser, PhD, James L Zehnder, Peter L Greenberg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4239.
https://doi.org/10.1182/blood-2019-129473
Published: 2019
Journal Articles

Single-Cell Mutational Profiling Describes the Molecular Heterogeneity of Clonal Evolution in MDS during Therapy and Relapse

Alexey Aleshin, MD MBA, Robert Durruthy-Durruthy, PhD, Bruno C. Medeiros, MD, Dennis J. Eastburn, PhD, Peter L Greenberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5503.
https://doi.org/10.1182/blood-2018-99-120368
Published: 2018
Journal Articles

Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms

Alexey Aleshin, MDMBA, Marianne A Santaguida, PhD, Michael A Spinner, MD, Jeffrey N Sanders, A Scott Patterson, Christos Gekas, PhD, Steven Schaffert, PhD, Peter L Greenberg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4356.
https://doi.org/10.1182/blood-2018-99-120146
Published: 2018
Journal Articles

Single-Cell Mutational Profiling of Clonal Evolution in De Novo AML during Therapy and Relapse

Alexey Aleshin, MD MBA, Robert Durruthy-Durruthy, PhD, M. Ryan Corces, PhD, Melissa Stafford, Michaela Liedtke, MD, Bruno C. Medeiros, MD, Dennis J. Eastburn, PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1469.
https://doi.org/10.1182/blood-2018-99-118089
Published: 2018